Novozymes A/S (OTCMKTS:NVZMY) Downgraded by Citigroup

Citigroup lowered shares of Novozymes A/S (OTCMKTS:NVZMY) from a neutral rating to a sell rating in a research note released on Thursday, Marketbeat.com reports.

Separately, Berenberg Bank raised shares of Novozymes A/S to a “strong-buy” rating in a research report on Tuesday, September 24th.

Novozymes A/S Stock Performance

NVZMY stock opened at $65.95 on Thursday. The company’s 50 day moving average price is $68.10 and its 200 day moving average price is $62.80. The firm has a market capitalization of $30.88 billion, a price-to-earnings ratio of 41.74, a PEG ratio of 3.87 and a beta of 0.89. Novozymes A/S has a fifty-two week low of $38.83 and a fifty-two week high of $72.50.

Novozymes A/S Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Wednesday, September 18th. Stockholders of record on Monday, September 9th were given a dividend of $0.1678 per share. The ex-dividend date was Monday, September 9th. Novozymes A/S’s dividend payout ratio is currently 41.77%.

About Novozymes A/S

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.